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Abstract
Introduction
The decline of malaria and scale-up of rapid diagnostic tests calls for a revision of IMCI. A
new algorithm (ALMANACH) running on mobile technology was developed based on the
latest evidence. The objective was to ensure that ALMANACH was safe, while keeping a
low rate of antibiotic prescription.
Methods
Consecutive children aged 2–59 months with acute illness were managed using ALMA-
NACH (2 intervention facilities), or standard practice (2 control facilities) in Tanzania. Pri-
mary outcomes were proportion of children cured at day 7 and who received antibiotics on
day 0.
Results
130/842 (154%) in ALMANACH and 241/623 (387%) in control arm were diagnosed with
an infection in need for antibiotic, while 38% and 96% had malaria. 815/838 (973%;961–
98.4%) were cured at D7 using ALMANACH versus 573/623 (920%;898–941%) using
standard practice (p<0001). Of 23 children not cured at D7 using ALMANACH, 44% had
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skin problems, 30% pneumonia, 26% upper respiratory infection and 13% likely viral infec-
tion at D0. Secondary hospitalization occurred for one child using ALMANACH and one
who eventually died using standard practice. At D0, antibiotics were prescribed to 154%
(129–179%) using ALMANACH versus 843% (814–871%) using standard practice
(p<0001). 23% (13–3.3) versus 32% (18–46%) received an antibiotic secondarily.
Conclusion
Management of children using ALMANACH improve clinical outcome and reduce antibiotic
prescription by 80%. This was achieved through more accurate diagnoses and hence better
identification of children in need of antibiotic treatment or not. The building on mobile tech-
nology allows easy access and rapid update of the decision chart.
Trial Registration
Pan African Clinical Trials Registry PACTR201011000262218
Introduction
About 7 million children under 5 years of age die each year despite the availability of effective
low-cost interventions [1]. The Integrated Management of Childhood Illness (IMCI) strategy
developed by the World Health Organization (WHO), UNICEF and other partners in mid
1990s [2] could potentially prevent two-thirds of these deaths [3]. To date, IMCI is still a good
tool and studies that assessed its impact showed borderline reduction of childhood mortality
[4]. When health workers were trained to use IMCI, their performance in case management
improved [5, 6], although cautious interpretation is needed due to heterogeneities in methodol-
ogies of assessment [6]. Worldwide, the impact of IMCI has been less than expected due to
health system challenges, such as shortage of health workers [7–9], poor motivation and lack of
supervision [10, 11]. All this leads to low compliance to the IMCI guidelines [12–14] and prob-
ably poorer health outcomes than it could be.
IMCI is facing additional challenges. First, a precise evaluation of the clinical outcome of
children when managed with the IMCI algorithm is lacking, which leaves a doubt about its real
benefit. Some studies evaluated the clinical outcome of children with specific diseases or condi-
tions, such as severe pneumonia at peripheral health facilities [15–17] or malaria and pneumo-
nia at community level [18, 19]. These studies also demonstrated that effectively trained and
supervised community health workers using malaria rapid diagnostic tests (mRDTs) with [18],
or without [19] respiratory rate (RR) timers could adequately classify and treat children less
than 5 years with malaria and/or pneumonia at community level. The overuse of antimalarials
was limited, but varying degrees of antibiotics over-prescription were observed [18]. Secondly,
patterns of disease and drug resistance have evolved dramatically in the last 20 years. The prev-
alence of malaria has considerably declined in the last decade across different settings [20].
While mRDT has just been incorporated in the new IMCI version [21], many national IMCI
guidelines still recommend to treat presumptively all febrile children with antimalarials. Third,
since the advent of mRDT, the proportion of patients receiving antibiotics has increased [22–
24], probably because clinicians have not enough guidance on how to proceed when mRDTs
results are negative. The new IMCI guidelines do not include precise guidance on typhoid
fever, urinary tract infections (UTI) or other causes of unspecific fever. Even if these conditions
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might have limited impact on mortality, they are feared by primary health care clinicians who
often prescribe antibiotics to prevent potential complications.
Based on the IMCI algorithm, a review of the literature, and the results of an etiology of
fever study conducted in Tanzania [25], a novel ALgorithm for the MANAgement of CHild-
hood illness (ALMANACH) was developed (Rambaud Althaus et al, submitted) (S1 File). This
algorithm was primarily aimed at decreasing unnecessary prescription of antibiotics in chil-
dren, while ensuring same or even better clinical outcome compared to routine practice (non
inferiority trial).The objective of the present study was to measure the impact of its use on clini-
cal outcome and antibiotic prescription in children attending primary care facilities in rural
and urban settings of Tanzania.
Materials and Methods
Study sites and subjects
The study was conducted as part of a larger project which aimed at improving the quality of
care and rational use of medicines for children in Tanzania (PeDiAtrick project, registration
number PACTR201011000262218 at www.pactr.org) (S2 File). For the present study, two pairs
(one from urban Dar es Salaam and one from the rural Morogoro region) of two nearby pri-
mary care health facilities (HF), similar in terms of natural environment, malaria prevalence,
socio-economic status of the catchment population, and type of services available, were conve-
niently selected. Then, in Dar es Salaam, Ilala municipality (city center), Buguruni was ran-
domly selected as intervention and Vingunguti as control HF; in Morogoro region, Kilombero
district, Signal was selected as intervention and Mangula as control. We chose to conduct the
study in different health facilities rather than to use a parallel design or recruit consecutively
patients in the same health facility because the latter increased the risk of including patients
with different disease frequency between the intervention (ALMANACH) and routine practice
arms due to seasonal variation. There was also the risk of biased results due to contamination
between arms because clinicians would have gained a better understanding of disease classifica-
tion or change their behaviour in terms of antimicrobial prescription because of the ALMA-
NACH training and use. Consecutive children aged 2 to 59 months were enrolled by trained
study nurse if they fulfilled the inclusion criteria: 1) first consultation for the current illness; 2)
absence of severe illness requiring immediate life-saving procedures; 3) main complaint(s) not
related to injury or trauma; 4) living in the catchment area of the HF and; 5) written informed
consent by the caretaker.
Study design and procedures
A controlled non-inferiority trial (S3 File) was conducted to compare the clinical outcome of
children managed according to ALMANACH or to standard practice. Children enrolled in the
intervention arm were managed by two study clinicians (one for each setting) who were trained
to strictly comply with the ALMANACH algorithm, which was available on paper at the start
of the study and used in the first 100 patients, and then built in an electronic support (smart-
phone running Open MRS) and used for the remaining 742 patients (S4 and S5 Files). Both
versions were identical. In the control arm, children were attended by the usual HF clinicians,
of which about 80% had been trained for IMCI [26]. In general, this training had taken place
several years before, and compliance to guidelines was known to be rather poor, with most
patients receiving antibiotics, especially when tested negative for malaria [22]. mRDT and
commonly prescribed medicines were made available throughout the study period in both
arms.
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During the one-month pilot phase, study clinicians in the ALMANACH arm received face-
to-face supervision with several real patients to check their ability to identify all relevant signs,
including RR measurement. In the control arm, no algorithm, training or supervision was per-
formed. Observing study clinician obtained oral consent from the routine clinician and
observed the consultation to record key information such as symptoms, signs, laboratory inves-
tigation(s) performed, diagnosis(es), advice to caretakers and treatment(s) prescribed. He was
instructed not to interfere with the consultation to avoid introducing additional bias to the
observer effect.
Ethics statement
All procedures followed the Good Clinical Practice guidelines. The study protocol and related
documents were approved by Ethikkommission beider Basel in Switzerland, by the Institu-
tional Review Board of the Ifakara Health Institute and by the National Institute for Medical
Research Review Board in Tanzania (NIMR/HQ/R.8a/Vol.IX/823).
Content of the ALMANACH algorithm
The development and content of ALMANACH is described in another paper (Rambaud
Althaus et al, submitted). In brief, this new algorithm was based on IMCI, but differed on some
key features presented in Table 1.
Management of children during spontaneous re-attendance
In the intervention arm, caretakers were informed to bring the child back to the study HF if he/
she was not able to drink or breastfeed, became sicker, developed fever, fast or difficult breath-
ing, or blood in stool. During working hours, sick children were reassessed by the study clini-
cian, and managed again according to ALMANACH. Out of working hours, children were
managed by routine clinicians who were asked to record demographic data, laboratory results,
Table 1. Key differences between the IMCI and the new ALgorithm for the MANAgement of Childhood illness (ALMANACH) (section dedicated to
the management of acute conditions in children aged 2 months to 5 years).
IMCI algorithm New algorithm (ALMANACH)
Danger signs 5 danger signs managed at the start: unable to drink or
breastfeed; lethargic or unconscious; vomits everything;
convulsing now or has had convulsions Six additional danger
signs assessed later: stridor; chest indrawing; sunken eyes; skin
pinch goes back very slowly; stiff neck; tender swelling behind
ear
10 danger signs managed at the start: unable to drink or
breastfeed; lethargic or unconscious; jaundice; vomits everything;
convulsing now or has had convulsions; cyanosis; severe pallor;
stiff neck and severe wasting Six additional danger signs
assessed later: stridor; chest indrawing;; sunken eyes; skin pinch
goes back very slowly; tender swelling behind ear; infected skin
lesion or lump larger than 4 cm or with red streaks or with tender
nodes or multiple abscesses
Fever 1 out of 4 Main symptoms A dividing point between a febrile branch and a non- febrile branch
Pneumonia Cough + fast breathinga Fever + cough + very fast breathingb
Urinary Tract
Infection
Not considered Febrile child<2 years with no source identified at this pointc, and
with a positive (leucocytes or nitrites) urine dipstick.
Typhoid fever Not considered Febrile child 2 years with no source identified at this pointc, and
with abdominal tenderness
Likely viral
infection
Not existing Febrile child with no classification at the end of the algorithm
a 50 breaths/min for children aged 2 to 12 months, 40 breaths/min for children aged 12 months to 5 years.
b 50 breaths/min for all children (aged 2 months to 5 years).
c No cough or difficult breathing, no diarrhea, no ear problem, no measles, no infected skin lesion or lump.
doi:10.1371/journal.pone.0132316.t001
PLOSONE | DOI:10.1371/journal.pone.0132316 July 10, 2015 4 / 15
diagnoses, treatments and need for referral in order to hand them back to the study clinician
the day after. In the control arm, children were advised on when to come back and managed
during re-attendance at the discretion of the routine clinician, who were asked to record the
same information on the re-attendances and to hand them back to the study team. In both
arms, information regarding visits to other health facilities than the study facilities, and on
additional treatment received, was recorded during the follow-up visit at day 7.
Follow-up of children at day 7 and 14
Caretakers in both arms were asked to bring back their child on day 7 to assess if he/she was
cured or not. Children were declared cured if the caretaker reported the child to be well. All
children reported as not cured were attended by the clinician and managed again according to
ALMANACH in the intervention arm and to usual practice in the control one. When the child
had not recovered at day 7, caretakers were asked to return on day 14 for a new assessment.
Caretakers whose children did not turn up at day 7 were reminded by phone about the visit
and, if not reached, visited at home.
Data collection, management and analysis
In the intervention arm, a standardized case report form (CRF) was completed during the
paper phase of the study. Data collection included demographics, all relevant symptoms and
signs, laboratory investigation(s), diagnosis(es), advice and treatment(s) received. During the
electronic phase (smartphone), a shorter version of the CRF was used not to repeat data that
were automatically sent to the server when running through the decision chart. In the control
arm, the observing study clinician filled another CRF that included all relevant information
mentioned above. The CRFs were adapted from the health facility survey checklist question-
naire developed by WHO [27].
Beside data sent directly from the smartphone to the server, all information was double-
entered in Epi-info software version 353 (CDC Atlanta, USA). Data management and analysis
were done using STATA software version 101 (College Station, Texas, USA). The primary out-
come measures were: i) proportion of children cured at day 7, and ii) proportion of children
who received antibiotics on day 0. Secondary outcome measures were i) proportion of children
admitted secondarily or who died, ii) proportion of children who received antibiotics during
the whole study period. The above proportions were compared between the intervention and
control group using Chi-square test and, when appropriate, Fisher exact test.
To calculate the sample size, we assumed that 95% of children managed with standard prac-
tice would be cured on day 7 [28]. To show non-inferiority of the intervention arm with a 3%
margin, 80% power and 0.05 level of significance, and using a ratio of 3:2 in order to have more
patients in the intervention arm, we calculated that 816 patients in the intervention and 544 in
the control arm were needed. Taking into account a 3% rate of loss to follow-up, the target
sample size was thus 840 and 560 patients in the intervention and control arms respectively.
Results
Status at inclusion
Between December 2010 and June 2011, 1467 children [median age 14 months) were enrolled,
844 (523 in the urban and 321 in the rural setting) in the ALMANACH and 623 (353 in the
urban and 270 in the rural setting) in the standard practice arm. Two children were then
excluded, one because he was not visiting the health facility for the first time for the current
problem, and one who was<2 months of age. Baseline characteristics of patients included are
PLOSONE | DOI:10.1371/journal.pone.0132316 July 10, 2015 5 / 15
presented in Table 2. The diagnoses distribution in the ALMANACH and standard practice
arms are featured in Fig 1. Acute respiratory infections (ARI), either alone or in combination
with another condition besides malaria, accounted for 57% and 58% of the diagnoses in inter-
vention and control arms. However, the classification within respiratory infections was quite
different between arms: 103% (95%CI 83–124%) were classified as having pneumonia in the
ALMANACH arm while 185% (154–215%) as having pneumonia and 170% (141–202%)
as having ARI (a diagnosis given by routine clinicians when they did not classify further the
respiratory infection but for which they tended to prescribe antibiotics) in the standard practice
arm. Only 10% (01–12%) in the ALMANACH versus 120% (93–144%) in the standard
practice arm were classified as having UTI. 38% (25–51%) were diagnosed with malaria
alone or in combination with another diagnosis in the ALMANACH versus 96% (73–120%)
in the standard practice arm, despite full availability of mRDT in all HFs.
Clinical outcome
Cure rate at day 7 and 14. 05% (4/842) of children in the ALMANACH and 02% (1/
623) in the standard practice arm were lost of follow-up. 973% children managed with
Table 2. Baseline characteristics of the patients in intervention (ALMANACH) and control (standard
practice) arms (n = 1465).
Characteristic ALMANACH Standard practice
n/N % n/N %
Gender
Females 407/842 483 300/623 482
Age (in months)
2–12 426/842 506 241/623 387
13–24 216/842 257 174/623 279
25–36 106/842 126 89/623 143
37–48 64/842 76 81/623 130
49–59 30/842 36 38/623 61
Main symptoms
Fever 571/842 678 511/623 820
Cough 498/842 59.1 355/623 570
Diarrhoea 184/842 219 76/623 122
Vomiting 57/842 68 78/623 125
Ear problem 14/842 17 13/623 15
Fast breathing
50 breaths per minute 100/351 285 42/310 136
Danger signs 1/842 01 5/623 08
Lethargic 1/842 01 0/623 0
Vomiting everything 0/842 0 1/623 02
Unable to drink/breastfeed 0/842 0 2/623 03
History of convulsion 0/842 0 2/623 03
Hospitalization at inclusion
Admission on day 0* 3/842 04 21/623 34
*The control health facility of the rural area (Mang’ula Health Center) had a higher number of admissions
on day zero because of the possibility to admit patients on site (unlike the intervention rural health facility
(Signal Dispensary).
doi:10.1371/journal.pone.0132316.t002
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ALMANACH were cured on day 7 versus 920% by standard practice (p<0001) (Table 3). In
the ALMANACH arm, of the 23 children not cured at day 7, 11 received an antibiotic on day 7;
22 were cured on day 14 and one on day 28 (Fig 2). 10 of these 23 (44%) children had been
diagnosed at inclusion with skin problems, either alone or in combination with another diag-
nosis, 7 (30%) with pneumonia, 7 (30%) with URTI, 3 (13%) with likely viral infection outside
URTI, and one patient with acute ear infection (Table 4). In the control arm, of the 50 children
Fig 1. Distribution of diagnoses at inclusion in the ALMANACH (A) and standard practice (B) arms. * Diagnosis given by clinicians when they do not
classify further the respiratory infection.
doi:10.1371/journal.pone.0132316.g001
Table 3. Clinical outcome and antimicrobials prescribed in children managed by ALMANACH and standard practice.
Outcome measure ALMANACH Standard practice p-value
n/N % 95%CI n/N % 95%CI
Clinical outcome
Cured on day 7 815/838 973 961–984 573/623 920 898–941 <0001
Cured on Day 14 837/838 999 966–100.1 621/622 998 995–1002 08
Antibiotics prescribed
On day 0 130/842 154 129–179 525/623 843 814–871 <0001
Between day 0 and 7 19/838 23* 13–33 20/623 32 18–46 03
On day 7 11/838 13 07–23 0/623 0 0 0003
Total (at any day) 160/838 190 163–216 545/623 875 849–901 <0001
Antimalarials prescribed
On day 0 33/842 39 26–52 41/623 66 46–85 002
Between day 0 and 7 1/838 01 -01–04 7/623 11 03–20 001
On day 7 0/838 0 0 2/623 03 -01–08 02
Total (at any day) 34/838 41 27–54 50/623 80 59–102 0001
* 10 patients received antibiotics from study clinicians during working hours and 9 from routine clinicians out of working hours.
doi:10.1371/journal.pone.0132316.t003
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not cured on day 7, 48 children were cured on day 14, one child died and one was lost of fol-
low-up (Fig 2).
Among diagnoses found in at least 10 children at inclusion, pneumonia (7/101 = 70%),
skin conditions alone (5/84 = 60%) and multiple conditions not requiring antibiotics (4/
81 = 49%) were the conditions leading to the highest proportions of clinical failure at day 7 in
the ALMANACH arm, and ARI (13/119 = 110%), skin conditions (3/28 = 110%) and diar-
rhea (3/33 = 90%) in the standard practice arm.
Complications. Of the 838 children managed with ALMANACH, one child with likely
viral infection on day 0 was brought by the caretaker on day 5 to a referral hospital where he
was diagnosed with cellulitis. He was hospitalized for 10 days, received antibiotics and had
recovered when visited on day 28. Of the 623 children managed by standard practice, two chil-
dren were hospitalized secondarily. One had diarrhoea on day 0 and received cotrimoxazole,
oral rehydration salt and zinc tablets. At day 3 he was brought to the same HF and diagnosed
Fig 2. Study profile.
doi:10.1371/journal.pone.0132316.g002
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with severe dehydration. He was admitted for one day, received ringer lactate intravenously
and was discharged the next day. At day 7 he had recovered. The other child was diagnosed
with pneumonia on day 0, received benzyl penicillin and amoxicillin, and was sent home. He
was brought 5 days later to another HF where he was admitted for the same diagnosis and died
4 days later (see Fig 2).
Spontaneous attendance before day 7. 42% of children (35/838) in the ALMANACH
and 51% (32/623) in the standard practice arm re-attended spontaneously between day 0 and
7 (p = 04). In the intervention arm, 19 (23%) patients were secondarily prescribed an antibi-
otic, 10 because of pneumonia, 5 diarrhea, 2 UTI, 1 cellulitis and one tonsillitis (Table 5). All
were cured at day 7, except the one who was hospitalized with cellulitis. Among 8 children who
developed pneumonia secondarily, 6 were<12 months and had a RR at inclusion between
36 and 48/min, and 2 were12 months and one had a RR of 42 (not measured for the other
child due to absence of cough). On the other hand, 30 children12 months with a RR be-
tween 40 and 50/min at inclusion did not develop pneumonia, and were cured at D7 without
antibiotic.
Table 4. Characteristics of the 23 patients who were not cured at day 7 in the ALMANACH arm. URTI = Upper respiratory tract infection,
RR = respiratory rate, NA = not available.
N° Age
(months)
Diagnosis at day 0 RR at
day 0
Antibiotic
prescribed on day 0
Diagnosis at day 7 Antibiotic
prescribed on day 7
Hospitalized Cured at
day 14
1 2 Severe pneumonia NA Yes Pneumonia Yes No Yes
2 6 Pneumonia 52 Yes Pneumonia Yes No Yes
3 6 Pneumonia 55 Yes Pneumonia Yes No Yes
4 7 Pneumonia NA Yes URTI and dysentery Yes No Yes
5 12 Pneumonia 53 Yes URTI and diarrhoea No No Yes
6 13 Pneumonia 66 Yes URTI No No Yes
7 7 Pneumonia and
impetigo
NA Yes Infected heat
rashes
No No Yes
8 23 URTI NA No Diarrhoea No No Yes
9 18 URTI NA No URTI No No Yes
10 9 URTI NA No Diarrhoea No No Yes
11 15 URTI and impetigo 32 No URTI and soft
tissue infection
Yes No Yes
12 10 URTI and impetigo 44 No Impetigo No No Yes
13 7 URTI, diarrhoea and
impetigo
36 No Pneumonia and
diarrhoea
Yes No Yes
14 10 URTI and scabies NA No Pneumonia Yes No Yes
15 12 Impetigo No Soft tissue infection Yes No Yes
16 16 Impetigo No Soft tissue infection Yes No Yes
17 10 Infected skin rashes No Skin abscess Yes No Yes
18 3 Scabies No URTI No No Yes
19 16 Fungal infection No Fungal infection No No Yes
20 12 Likely viral infection NA No URTI No No Yes
21 20 Likely viral infection NA No URTI No No Yes
22* 11 Likely viral infection NA No Cellulitis Yes Yes No
23 38 Acute ear infection No Acute ear discharge Yes No Yes
* This patient is the same as patient n°8 in Table 5. He was secondarily admitted for cellulitis on day 5, received antibiotics on admission, was discharged
after 10 days and was cured on day 28.
doi:10.1371/journal.pone.0132316.t004
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Treatment prescribed
154% (130/842) of children managed with ALMANACH received antibiotics on day 0 com-
pared to 843% (525/623) by standard practice (p<0001). In the ALMANACH arm, only 19
(23%) and 11 (13%) children out of 842 received antibiotics secondarily, during spontaneous
attendance and visit at day 7 respectively. The cumulative proportion of children prescribed
antibiotics over the whole follow-up period (on day 0, between day 0 and day 7 and on day 7)
was 190% in the intervention versus 875% in the control arm (p<0001) (Table 3). In the
ALMANACH arm, the diagnoses at inclusion present in at least 10 patients for which antibiot-
ics were most frequently prescribed secondarily were pneumonia (8/101 = 79%), likely viral
infection (6/96 = 63%) and skin problem (4/84 = 48%).
Discussion
When strictly applied, the new ALMANACH algorithm resulted in better clinical outcome
than standard practice, and in 80% reduction of antibiotics prescribed to children with acute
illness. These improvements are probably due to a better identification of children with likely
viral infection, and hence not needing antibiotics, while still identifying those with bacterial
infections, or at least those who were likely to benefit from antibiotics.
Table 5. Characteristics of the 19 patients who received antibiotics during re-attendance in the ALMANACH arm.
N
°
Age
(months)
Diagnosis at day
0
Respiratory rate
at day 0
Antibiotic
prescribed on day 0
Clinician who
prescribed antibiotics*
Diagnosis at re-
attendance visit
Cured at
day 7
1 10 Pneumonia 53 Yes Study Pneumonia Yes
2 8 Pneumonia NA Yes Routine Pneumonia Yes
3 10 Pneumonia 52 Yes Study UTI Yes
4 8 Pneumonia and
measles
52 Yes Routine Diarrhoea Yes
5 18 Likely viral
infection
NA No Study Pneumonia Yes
6 21 Likely viral
infection
NA No Study Tonsillitis Yes
7 56 Likely viral
infection
NA No Study UTI Yes
8& 11 Likely viral
infection
NA No Study Cellulitis No
9 10 Likely viral
infection
NA No Routine Diarrhoea Yes
10 37 Likely viral
infection
NA No Routine Diarrhoea Yes
11 6 URTI 46 No Study Pneumonia Yes
12 4 URTI NA No Study Pneumonia Yes
13 5 URTI NA No Routine Pneumonia Yes
14 11 URTI 40 No Routine Pneumonia Yes
15 13 URTI 42 No Routine Pneumonia Yes
16 8 URTI and
diarrhoea
48 No Study Pneumonia Yes
17 5 UTI Yes Study Pneumonia Yes
18 9 Diarrhoea No Routine Diarrhoea Yes
19 36 Impetigo No Routine Diarrhoea Yes
*Out of working hours, the patient was evaluated and managed by a routine clinician of the HF rather than the study clinician.
&This patient is the same as patient n°22 in Table 4.
doi:10.1371/journal.pone.0132316.t005
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The rate of clinical failure with ALMANACH was expected to be equivalent to that of the
control arm, because the standard practice in Tanzania is to prescribe antibiotics to most of the
febrile patients, especially when mRDT are available [22]. One could have even expected more
failures with ALMANACH since the algorithm withholds antibiotics (compared to IMCI) in
frequent clinical situations such as cough and RR between 40 and 50/min in children12
months, or for children without a classification at the end of the algorithm (likely viral infec-
tion). On the contrary, we observed a better cure rate with ALMANACH, probably because cli-
nicians were able to better identify and treat children with possible bacterial infection.
Moreover, the better outcome at day 7 was neither at the price of a higher rate of spontaneous
re-attendance, nor of secondary prescription of antibiotics. These rates were indeed almost
identical in both arms. These findings suggest that significant bacterial infections were not
missed when using ALMANACH, which is the big fear of clinicians and their main reason to
give antibiotics. They often wrongly believe that antibiotics prevent secondary bacterial infec-
tions. Their behavior is also due to clinical guidelines that are often ambiguous, including the
latest 2014 version of IMCI that recommends to ‘Give appropriate antibiotic treatment for an
identified bacterial cause of fever’ to febrile children that are negative for malaria [29]. Such a
recommendation has a high risk to increase over-prescription of antibiotics. Policy makers
sometimes argue that children will not be brought back if their condition worsens, because of
long distance from home to health facilities, lack of transport and of cash money etc. The good
clinical outcome observed in the intervention arm suggests that caretakers did come back
when their child was worse, maybe because of clear messages given by clinicians. The present
study thus demonstrates that giving antibiotics to all children at first place to prevent re-atten-
dances or complications is not worth; it does not improve clinical outcome, provided the few
children who need antibiotics are accurately identified.
Giving unnecessary antibiotics does have deleterious consequences, namely the rapid spread
of bacterial resistance, unnecessary adverse drug reactions, and unnecessary cost. In Tanzania,
high levels of antibiotic resistance have already been reported [30, 31]. Also, children infected
with resistant microorganisms are more likely to die [32]. Unfortunately the different
approaches to reduce antibiotic prescription have been largely ineffective. In a systematic
review, educational/training interventions successfully improved targeted antibiotic prescrib-
ing outcomes by only 20%, and these changes were not sustainable over time [33]. Holistic
strategies are needed to contain antibiotic resistance, including the use of electronic decision
support to improve clinician’s compliance to guidelines. Such a strategy using electronic algo-
rithms for the management of childhood illness in a rural dispensary in Tanzania showed
promises [34]. The next step is thus to further evaluate this electronic ALMANACH in pro-
grammatic conditions.
Clinical failure and/or secondary antibiotic prescription according to
diagnosis type in ALMANACH arm
Among children managed using ALMANACH, the diagnosis that led to the highest rate of
clinical failure was pneumonia (7%), which also led to the highest rate of secondary antibiotic
prescription (8%). In contrast, URTI was rarely associated with clinical failures (1%) or second-
ary antibiotic prescription (2%). Because the vast majority of ARI are located in the upper tract
and of viral origin, these children do not require antibiotics and cure by themselves. In young
children, even most of lower respiratory tract infections, including pneumonias, are due to
viruses and will thus not improve with the provision of antibiotics. This also explains why a sig-
nificant number of these patients were not cured at day 7.
PLOSONE | DOI:10.1371/journal.pone.0132316 July 10, 2015 11 / 15
The second diagnosis that led to the highest rate of clinical failure (6%) and secondary anti-
biotic prescription (5%) was skin conditions. Skin problems are not included in the main algo-
rithm of IMCI algorithm. Half of the skin problems were mild infections such as impetigo that
had worsened enough to require antibiotics at day 7. The other half corresponded to skin prob-
lems that took longer than 7 days to cure such as fungal infection or stable impetigo, but that
did not require secondary antibiotics.
A ‘likely viral infection’ was the third diagnosis that led to a relatively high rate (6%) of sec-
ondary antibiotic prescription, but to a rather low rate (3%) of clinical failure at day 7. Antibi-
otics were given during follow-up because of the emergence of various conditions such as
pneumonia, tonsillitis, UTI, cellulitis and diarrhea. This diversity shows that it is not possible
to predict at day 0 if, and what these children may develop in the following days. The only safe
and rational solution is thus to evaluate them again when they do not improve. The aim of an
efficient clinical algorithm is indeed not to have zero follow-up visits, but rather to have no
child dying because of a delay once antibiotic are required. The message to bring the child back
in case of persisting or worsening condition, or emergence of a new health problem seems to
have been followed appropriately, as only one child has been secondarily admitted. When used
wisely, it prevents a lot of unnecessary prescription of antibiotics during first clinical
encounter.
Limitations of the study
One can argue that the appropriate control arm would have been a perfectly complied to IMCI
algorithm. However, no study on the clinical outcome of children strictly managed according
to IMCI has been performed in the past, so such results could not be used as gold standard.
Also a perfectly implemented IMCI does not exist, which shows its limitation in terms of feasi-
bility. We opted thus for the use of IMCI in real life conditions (routine practice) for the con-
trol arm to assess more precisely the public health benefit of the ALMANACH.
The new algorithm was implemented in controlled conditions, which is a necessary step
before implementation in routine conditions. Its real impact, which should directly depend on
the level of uptake and compliance by clinicians, needs to be precisely evaluated. We already
performed this step in a study investigating health worker’s performance when using ALMA-
NACH in pragmatic conditions (reported in Rambaud-Althaus et al, submitted).
No formal assessment of health worker satisfaction when using electronic devices was made
in the present study. Previous findings from a pilot study conducted in Tanzania assessing the
use of electronic IMCI showed that clinicians were enthusiastic to use it. However, this was not
enough justification to believe that the clinicians would indeed follow the “standard practice
ALMANACH” better than standard/routine practice. We also performed subsequently a quali-
tative study to assess health workers’ perception on barriers and facilitators for uptake of the
ALMANACH algorithm in pragmatic conditions over time (reported in Shao et al, submitted).
Conclusion
The new ALMANACH algorithm for the management of childhood illness, primarily aimed at
the rational use of antimicrobials, improved clinical outcome and led to a drastic reduction of
unnecessary antibiotic prescription when compared to standard practice. This achievement
was related to more precise diagnoses and better identification of children with infections that
required and did not require antibiotics. These results, obtained in both urban and rural places,
are probably generalizable for most locations in Sub-Saharan Africa, and even wider, since the
distribution of diagnoses in small children does not vary so much across regions and over-pre-
scription of antibiotics is a widespread problem in low resource settings [35]. The building on
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mobile technology allowed easy access for clinicians and rapid update of the decision chart
when new recommendations are put in place. Further studies are underway to assess the appro-
priateness and feasibility of using this electronic algorithm in routine practice.
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